PTPRN and MODY: In a Czech MODY cohort, autoantibodies to glutamic acid decarboxylase (GAD) or islet antigen-2 (IA-2) were detected in 25% of cases, and a positive autoantibody status was reported in 17% of patients in a series from Germany and Austria [25].